X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1025) 1025
Publication (236) 236
Book Chapter (17) 17
Patent (11) 11
Book / eBook (7) 7
Book Review (7) 7
Web Resource (7) 7
Conference Proceeding (5) 5
Reference (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (592) 592
child (479) 479
male (334) 334
female (329) 329
oncology (309) 309
adolescent (306) 306
child, preschool (302) 302
index medicus (275) 275
hematology (221) 221
children (216) 216
infant (208) 208
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (179) 179
article (162) 162
precursor cell lymphoblastic leukemia-lymphoma - genetics (153) 153
cancer (147) 147
leukemia (146) 146
acute lymphoblastic-leukemia (143) 143
chemotherapy (142) 142
prognosis (128) 128
risk factors (124) 124
adult (122) 122
pediatrics (121) 121
treatment outcome (102) 102
precursor cell lymphoblastic leukemia-lymphoma - therapy (100) 100
therapy (97) 97
antineoplastic combined chemotherapy protocols - therapeutic use (96) 96
childhood (84) 84
acute lymphocytic leukemia (83) 83
abridged index medicus (80) 80
research (79) 79
risk (78) 78
precursor cell lymphoblastic leukemia-lymphoma - pathology (75) 75
remission induction (74) 74
acute lymphoblastic leukemia (72) 72
retrospective studies (71) 71
care and treatment (69) 69
minimal residual disease (66) 66
medicine, general & internal (60) 60
acute lymphocytic-leukemia (59) 59
recurrence (59) 59
acute myeloid-leukemia (57) 57
disease-free survival (56) 56
precursor cell lymphoblastic leukemia-lymphoma - mortality (54) 54
young adult (50) 50
health aspects (49) 49
pediatric-oncology-group (49) 49
methotrexate (46) 46
precursor cell lymphoblastic leukemia-lymphoma - complications (46) 46
antineoplastic agents - therapeutic use (45) 45
methotrexate - administration & dosage (45) 45
survivors (43) 43
acute lymphatic leukemia (40) 40
follow-up studies (40) 40
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (40) 40
acute disease (39) 39
genetic aspects (39) 39
time factors (39) 39
expression (38) 38
precursor cell lymphoblastic leukemia-lymphoma - metabolism (37) 37
survival analysis (37) 37
survival rate (37) 37
analysis (36) 36
cohort studies (36) 36
children & youth (34) 34
immunophenotyping (34) 34
drug therapy (33) 33
genetics & heredity (33) 33
mutation (33) 33
patient outcomes (33) 33
age factors (32) 32
disease (32) 32
genotype (32) 32
long-term survivors (32) 32
polymorphism, single nucleotide (32) 32
cancer in children (31) 31
combined modality therapy (31) 31
diagnosis (31) 31
hemic and lymphatic diseases (31) 31
relapse (31) 31
risk assessment (31) 31
incidence (30) 30
antineoplastic agents - adverse effects (29) 29
genome-wide association study (29) 29
pharmacology & pharmacy (29) 29
survival (29) 29
acute myeloid leukemia (28) 28
gene expression (28) 28
gene expression profiling (28) 28
original reports (28) 28
phenotype (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (27) 27
genetic predisposition to disease (27) 27
karyotyping (27) 27
prospective studies (27) 27
high-dose methotrexate (26) 26
infant, newborn (26) 26
methotrexate - adverse effects (26) 26
pharmacogenetics (26) 26
antineoplastic combined chemotherapy protocols - administration & dosage (25) 25
cranial irradiation (25) 25
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
About 25% of young adults with ALL have Ph-like genotypes, which are associated with poor outcomes with conventional treatment. In this gene-expression study,... 
MEDICINE, GENERAL & INTERNAL | MODELS | B-CELL PRECURSOR | INHIBITOR THERAPY | IMATINIB | PEDIATRIC ACUTE LEUKEMIAS | GENE FUSION | EXPRESSION | ETV6-NTRK3 FUSION TRANSCRIPTS | CRLF2 | DELETION | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Adolescence | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Cell lines
Journal Article
Leukemia, ISSN 0887-6924, 04/2004, Volume 18, Issue 4, pp. 676 - 684
To develop a therapy for drug-resistant B-lineage acute lymphoblastic leukemia (ALL), we transduced T lymphocytes with anti-CD19 chimeric receptors, consisting... 
T-cell receptor | CD137 | Acute lymphoblastic leukemia | B-cell lymphoma | STEM-CELLS | ALLOGENEIC CELL THERAPY | DONOR LEUKOCYTE INFUSIONS | BONE-MARROW-TRANSPLANTATION | VERSUS-HOST DISEASE | ONCOLOGY | acute lymphoblastic leukemia | IN-VIVO | GENE-TRANSFER | HEMATOLOGY | B-LINEAGE LEUKEMIA | T-CELLS | LYMPHOCYTES | Cytotoxicity Tests, Immunologic | Recombinant Fusion Proteins - pharmacology | CD8 Antigens - pharmacology | Coculture Techniques | Humans | Tumor Necrosis Factor Receptor Superfamily, Member 9 | Receptors, Tumor Necrosis Factor - therapeutic use | Burkitt Lymphoma - pathology | Immunoconjugates - pharmacology | CD3 Complex - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | T-Lymphocytes - metabolism | Immunotherapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Receptors, Nerve Growth Factor - therapeutic use | Antigens, CD19 - immunology | Receptors, Tumor Necrosis Factor - genetics | Burkitt Lymphoma - therapy | Protein Structure, Tertiary | Transduction, Genetic | CD3 Complex - pharmacology | Receptors, Nerve Growth Factor - genetics | CD8 Antigens - chemistry | T-Lymphocytes - cytology | Immunoconjugates - genetics | CD8 Antigens - genetics | Immunoglobulin Variable Region - pharmacology | Cell Line, Tumor | Recombinant Fusion Proteins - genetics | Immunoglobulin Variable Region - genetics | T-Lymphocytes - immunology | CD3 Complex - chemistry | Antigens, CD
Journal Article
1999, ISBN 0521581761, xii, 567
Book
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 24, pp. 2336 - 2346
Journal Article